Global Smoking Cessation Drugs Market 2016-2020

About Smoking Cessation Products

Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking.

Technavio’s analysts forecast the global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American
Other prominent vendors
  • 22nd Century Group
  • Alkalon
  • Altria Group
  • Aradigm
  • Arena Pharmaceuticals
  • Ballantyne Brands
  • British American Tobacco (BAT)
  • CB Distributors
  • Cytos Biotechnology
  • Electronics Cigarettes International Group (Victory Electronic Cigarettes)
  • Evotec
  • Gamucci
  • Japan Tobacco
  • Johnson & Johnson
  • LOGIC Technology
  • NAL Pharmaceuticals
  • Nicotek
  • Novartis
  • Revolymer
  • RR Chemicals
  • Selecta Biosciences
  • Target
  • The Harvard Drug Group
  • Vapor
  • VMR Products
  • Walgreens
  • Wal-Mart
  • White Cloud
Market driver
  • High awareness of risks associated with tobacco use
  • For a full, detailed list, view our report
Market challenge
  • Relapse after treatment
  • For a full, detailed list, view our report
Market trend
  • Ban on tobacco advertisements
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Smoking Cessation Products Market 2016-2020

Technavio recognizes the following companies as the key players in the global smoking cessation products market: GlaxoSmithKline, Imperial Tobacco, NJOY, Pfizer, and Reynolds American.

Other Prominent Vendors in the market are: 22nd Century Group, Alkalon, Altria Group, Aradigm, Arena Pharmaceuticals, Ballantyne Brands, British American Tobacco (BAT), CB Distributors, Cytos Biotechnology, Electronics Cigarettes International Group (Victory Electronic Cigarettes), Evotec, Gamucci, Japan Tobacco, Johnson & Johnson, LOGIC Technology, NAL Pharmaceuticals, Nicotek, Novartis, Revolymer, RR Chemicals, Selecta Biosciences, Target, The Harvard Drug Group, Vapor, VMR Products, Walgreens, Wal-Mart, and White Cloud.

Commenting on the report, an analyst from Technavio’s team said: “A ban on tobacco advertisements around the world has had a positive effect on consumers. The report showed a decline of at least 16% in tobacco consumption compared to the pre-ban days. However, only 29 countries, which constitute 12% of the world's population, have banned these advertisements. Globally, one-third of countries have imposed a minimal restriction on tobacco advertisements and campaigns. It is estimated that around 78% of youngsters aged 13-15 years are exposed to advertisement or promotions for tobacco, leading them to experiment with the product.”

According to the report, more people are becoming aware of the risks associated with tobacco use. Around six million users of tobacco die every year and this number is set to increase to eight million by 2030. Cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases are also caused due to tobacco use. Tobacco smoke consists of over 4,000 chemical compounds, with about 69 chemicals that are potentially known to cause cancer. These chemicals harm not only smokers, but also second-hand smokers who inhale the smoke in public spaces. Another area where the harmful effects of tobacco are witnessed are in tobacco farming, where young children from underprivileged families are often employed.

Further, the report states that the side effects associated with drugs and therapies may hinder market growth.

Companies Mentioned

GlaxoSmithKline, Imperial Tobacco, NJOY, Pfizer, Reynolds American, 22nd Century Group, Alkalon, Altria Group, Aradigm, Arena Pharmaceuticals, Ballantyne Brands, British American Tobacco (BAT), CB Distributors, Cytos Biotechnology, Electronics Cigarettes International Group (Victory Electronic Cigarettes), Evotec, Gamucci, Japan Tobacco, Johnson & Johnson, LOGIC Technology, NAL Pharmaceuticals, Nicotek, Novartis, Revolymer, RR Chemicals, Selecta Biosciences, Target, The Harvard Drug Group, Vapor, VMR Products, Walgreens, Wal-Mart, White Cloud.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • World cigarette statistics: Per capita consumption per year
  • Epidemiology
    • US
  • Health implications of smoking
    • Table Common health effects caused by smoking
    • Risk of tobacco smoke on non-smokers
  • Regulations on tobacco use
    • Impact of smoking bans on businesses
    • Economic benefits to individuals
  • Pipeline analysis
    • Table Smoking cessation products: Pipeline portfolio
    • Table Discontinued projects
    • NAL2762
    • X-22
    • APD356
    • GSK598809
    • SEL-068
    • ARD-1600
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global smoking cessation products market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by type
    • Table Global smoking cessation products market by type
    • Table Global smoking cessation products market by type 2015
    • Global smoking cessation drugs market
      • Table Global smoking cessation drugs market 2015-2020 ($ billions)
    • Global NRTs market
      • Table Global NRTs market 2015-2020 ($ billions)
      • Table Global NRTs market by product 2015
      • Table Global nicotine patch market 2015-2020 ($ billions)
      • Table Nicotine patch market by geographical region 2015
      • Table Global nicotine gum market 2015-2020 ($ billions)
      • Table Nicotine gum market by geographical region 2015
    • Global e-cigarette market
      • Table Global e-cigarette market 2015-2020 ($ billions)
      • Table Global e-cigarette market: Product life cycle analysis 2015
      • Table E-cigarette market by geographical region 2015
  • Market segmentation by availability
    • Table Global smoking cessation products market by availability
    • Prescription products
    • OTC products
  • Geographical segmentation
    • Global smoking cessation products market by geography 2015-2020
      • Table Global smoking cessation products market by geography 2015
      • Table Global smoking cessation products market by geography 2020
      • Table Global smoking cessation products market revenue by geography 2015-2020 ($ billions)
    • Smoking cessation products market in Americas
      • Table Smoking cessation products market in Americas 2015-2020 ($ billions)
    • Smoking cessation products market in EMEA
      • Table Smoking cessation products market in EMEA 2015-2020 ($ billions)
    • Smoking cessation products market in APAC
      • Table Smoking cessation products market in APAC 2015-2020 ($ billions)
  • Market drivers
    • Increase in number of smokers
    • Increase in teenage smoking
    • Significant number of public awareness programs
    • High awareness of risks associated with tobacco use
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Side effects associated with drugs and therapies
    • Relapse after treatment
    • Weak R&D on drugs
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increase in use of e-cigarettes
    • Increased innovation in smoking cessation products
    • Ban on tobacco advertisements
    • Increased pictorial warnings on cigarette packages
      • Table Implementation of picture warnings in various countries
  • Vendor landscape
    • Competitive scenario
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Business segmentation by revenue 2014
      • Table GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table GlaxoSmithKline: Geographical segmentation by revenue 2014
      • Table GlaxoSmithKline: Key takeaways
    • Imperial Tobacco
      • Table Imperial Tobacco: Business segmentation by revenue 2014
      • Table Imperial Tobacco: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Imperial Tobacco: Key takeaways
    • NJOY
      • Table NJOY: Product categories
      • Table NJOY: Key takeaways
    • Pfizer
      • Table Pfizer: Business segmentation by revenue 2014
      • Table Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Pfizer: Geographical segmentation by revenue 2014
      • Table Pfizer: YoY growth and revenue of Chantix or Champix ($ millions)
      • Table Pfizer: Key takeaways
    • Reynolds American
      • Table Reynolds American: Business segmentation by revenue 2014
      • Table Reynolds American: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Reynolds American: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook